SCHEMBL30029207

SCHEMBL30029207

Cn1nc(C2CCC(=O)NC2=O)c2ccc(NCC(=O)N3CCN(C(=O)OC(C)(C)C)CC3)cc21

nearest known ligand 0.81

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 15/20 0.81
▸ CRBN Q96SW2 15/20 0.81
▸ GPR119 Q8TDV5 5/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20805490 0.90 DDB1 (1.00) DDB1CRBNGPR119
SCHEMBL29984027 0.90 DDB1 (1.00) DDB1CRBNGPR119
SCHEMBL30794089 0.88 DDB1 (0.74) DDB1CRBNGPR119
SCHEMBL30793998 0.88 DDB1 (0.74) DDB1CRBNGPR119
SCHEMBL24530623 0.87 CRBN (0.61) DDB1CRBN
SCHEMBL31554657 0.87 DDB1 (0.80) DDB1CRBN
SCHEMBL30029251 0.87 CRBN (0.66) DDB1CRBN
SCHEMBL24754186 0.87 CRBN (0.66) DDB1CRBN
SCHEMBL26259198 0.86 CRBN (0.60) DDB1CRBN
SCHEMBL30661527 0.85 DDB1 (0.80) DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022266248-A1 SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2022-12-22 — — WO disclosed
WO-2022266249-A1 KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2022-12-22 — — WO disclosed
Send feedback